Kleinstein, Sarah E.
Shea, Patrick R.
Allen, Andrew S.
Koelle, David M. http://orcid.org/0000-0003-1255-9023
Wald, Anna
Goldstein, David B.
Article History
Received: 6 July 2017
Revised: 24 November 2017
Accepted: 1 December 2017
First Online: 28 February 2018
Compliance with ethical standards
:
: SEK, PRS, and ASA declare that they have no conflict of interest. DMK is a consultant to Glaxo SmithKline and has research grants or contracts from Immune Design Corporation, Admedus Vaccines, Merck, and Sanofi Pasteur. DMK and AW are co-inventors on patents owned by the University of Washington. AW receives research funding from Genocea and Vical and is a consultant for Aicuris. DBG receives research funding from Janssen, AstraZeneca, Gilead, Biogen, and UCB, is a consultant for AstraZeneca, and holds a patent for IL28B findings.